Prostate cancer is a prevalent and debilitating disease that necessitates effective prevention and treatment strategies. Green tea

a well-known beverage derived from the

Camellia sinensis

plant

contains bioactive compounds with potential health benefits

including catechins and polyphenols. This comprehensive review aims to explore the potential benefits of green tea in prostate cancer prevention and treatment by examining existing literature. Green tea possesses antioxidant

anti-inflammatory

and anti-carcinogenic properties attributed to its catechins

particularly epigallocatechin gallate. Epidemiological studies have reported an inverse association between green tea consumption and prostate cancer risk

with potential protection against aggressive forms of the disease. Laboratory studies demonstrate that green tea components inhibit tumor growth

induce apoptosis

and modulate signaling pathways critical to prostate cancer development and progression. Clinical trials and human studies further support the potential benefits of green tea. Green tea consumption has been found to be associated with a reduction in prostate-specific antigen levels

tumor markers

and played a potential role in slowing disease progression. However

challenges remain

including optimal dosage determination

formulation standardization

and conducting large-scale

long-term clinical trials. The review suggests future research should focus on combinatorial approaches with conventional therapies and personalized medicine strategies to identify patient subgroups most likely to benefit from green tea interventions.